Black Rock Inc. Century Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,895,613 shares of IPSC stock, worth $2.11 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,895,613
Previous 1,498,181
93.28%
Holding current value
$2.11 Million
Previous $6.26 Million
17.9%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding IPSC
# of Institutions
71Shares Held
33.6MCall Options Held
9.7KPut Options Held
1.5K-
Bain Capital Life Sciences Investors, LLC Boston, MA5.41MShares$3.95 Million1.48% of portfolio
-
Casdin Capital, LLC New York, NY5.19MShares$3.79 Million0.45% of portfolio
-
Vr Adviser, LLC New York, NY3.96MShares$2.89 Million0.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.38MShares$1.74 Million0.0% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA1.7MShares$1.24 Million0.47% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $43M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...